X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (57) 57
humans (56) 56
female (45) 45
male (45) 45
hepatitis c, chronic - drug therapy (42) 42
middle aged (42) 42
adult (38) 38
gastroenterology & hepatology (37) 37
hepacivirus - genetics (27) 27
antiviral agents - therapeutic use (26) 26
drug therapy, combination (26) 26
hepatitis c (25) 25
genotype (24) 24
treatment outcome (24) 24
antiviral agents - administration & dosage (23) 23
hepatitis (22) 22
aged (21) 21
sofosbuvir (21) 21
hepatitis c, chronic - virology (19) 19
ribavirin (19) 19
hepatitis c virus (18) 18
interferon (17) 17
plus ribavirin (17) 17
ribavirin - administration & dosage (17) 17
hepacivirus - drug effects (16) 16
uridine monophosphate - analogs & derivatives (16) 16
abridged index medicus (15) 15
telaprevir (15) 15
antiviral agents - adverse effects (14) 14
clinical trials (14) 14
double-blind method (13) 13
drug therapy (13) 13
genotype & phenotype (13) 13
liver cirrhosis (13) 13
viral nonstructural proteins - antagonists & inhibitors (13) 13
young adult (13) 13
antiviral agents (12) 12
care and treatment (12) 12
health aspects (12) 12
therapy (12) 12
gastroenterology and hepatology (11) 11
infection (11) 11
interferon-alpha - administration & dosage (11) 11
polyethylene glycols - therapeutic use (11) 11
ribavirin - therapeutic use (11) 11
boceprevir (10) 10
drug administration schedule (10) 10
hepatitis c - drug therapy (10) 10
interferon-alpha - therapeutic use (10) 10
medicine, general & internal (10) 10
polyethylene glycols - administration & dosage (10) 10
viral load (10) 10
virus-infection (10) 10
adolescent (9) 9
biological response modifiers (9) 9
cirrhosis (9) 9
infections (9) 9
pharmacology & pharmacy (9) 9
protease inhibitors (9) 9
sustained virologic response (9) 9
uridine monophosphate - therapeutic use (9) 9
drug resistance, viral (8) 8
fibrosis (8) 8
in-vitro (8) 8
liver (8) 8
patients (8) 8
proteases (8) 8
replication (8) 8
sustained virological response (8) 8
analysis (7) 7
combination (7) 7
double-blind (7) 7
drug resistance, viral - genetics (7) 7
genetic aspects (7) 7
hcv (7) 7
hepatitis c, chronic - genetics (7) 7
medical research (7) 7
microbiology (7) 7
recombinant proteins - administration & dosage (7) 7
ribavirin - adverse effects (7) 7
rna, viral - blood (7) 7
treatment-naive patients (7) 7
uridine monophosphate - administration & dosage (7) 7
virus diseases (7) 7
benzimidazoles - therapeutic use (6) 6
biopsy (6) 6
chronic hepatitis-c (6) 6
dose-response relationship, drug (6) 6
genotypes (6) 6
hepatitis c, chronic - complications (6) 6
imidazoles - administration & dosage (6) 6
medicine, experimental (6) 6
ns5a inhibitor (6) 6
polyethylene glycols - adverse effects (6) 6
recombinant proteins (6) 6
recombinant proteins - therapeutic use (6) 6
resistance (6) 6
benzimidazoles - adverse effects (5) 5
chronic infection (5) 5
combination therapy (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9883, pp. 2100 - 2107
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 705 - 716
Journal Article
by Younossi, Zobair M and Ratziu, Vlad and Loomba, Rohit and Rinella, Mary and Anstee, Quentin and Anstee, Quentin M and Goodman, Zachary and Bedossa, Pierre and Geier, Andreas and Beckebaum, Susanne and Newsome, Philip N and Newsome, Philip and Sheridan, David and Sheikh, Muhammad and Sheikh, Aasim and Sheikh, Muhammad Y and Trotter, James and Knapple, Whitfield and Lawitz, Eric and Abdelmalek, Manal F and Abdelmalek, Manal and Kowdley, Kris V and Kowdley, Kris and Montano-Loza, Aldo J and Montano-Loza, Aldo and Boursier, Jerome and Mathurin, Philippe and Bugianesi, Elisabetta and Mazzella, Giuseppe and Olveira, Antonio and Cortez-Pinto, Helena and Graupera, Isabel and Orr, David and Orr, James and Gluud, Lise Lotte and Dufour, Jean-Francois and Dufour, Jean-François and Shapiro, David and Campagna, Jason and Zaru, Luna and MacConell, Leigh and Shringarpure, Reshma and Harrison, Stephen and Sanyal, Arun and Sanyal, Arun J and Abrams, Gary and Aguilar, Humberto and Ahmed, Aijaz and Aigner, Elmar and Aithal, Guruprasad and Ala, Aftab and Alazawi, William and Albillos, Agustin and Allison, Michael and Al-Shamma, Sfa and Andrade, Raul and Andreone, Pietro and Angelico, Mario and Ankoma-Sey, Victor and Anty, Rodolphe and Araya, Victor and Arenas Ruiz, Juan Ignacio and Arkkila, Perttu and Arora, Marty and Asselah, Tarik and Au, Jennifer and Ayonrinde, Oyekoya and Bailey, Robert James and Balakrishnan, Maya and Bambha, Kiran and Bansal, Meena and Barritt, Sidney and Bate, John and Beato, Jorge and Behari, Jaideep and Bellot, Pablo and Ben Ari, Ziv and Bennett, Michael and Berenguer, Marina and Beretta-Piccoli, Benedetta Terziroli and Berg, Thomas and Bonacini, Maurizio and Bonet, Lucia and Borg, Brian and Bourliere, Marc and Bowman, William and Bradley, David and Brankovic, Marija and Braun, Marius and Bronowicki, Jean-Pierre and Bruno, Savino and Cai, Cindy and Calleja Panero, José Luis and Carey, Elizabeth and Carmiel, Michal and Carrión, Jose Antonio and Cave, Matthew and Chagas, Cristina and Chami, Tawfik and Chang, Alan and ... and REGENERATE Study Investigators
The Lancet, ISSN 0140-6736, 12/2019, Volume 394, Issue 10215, pp. 2184 - 2196
Journal Article
The Lancet, ISSN 0140-6736, 12/2018, Volume 392, Issue 10165, pp. 2705 - 2717
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9956, pp. 1756 - 1765
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1075 - 1086
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 401 - 408
Summary Background Protease inhibitors have improved treatment of infection with hepatitis C virus (HCV), but dosing, a low barrier to resistance, drug... 
Infectious Disease | PSI-7977 | INFECTIOUS DISEASES | PLUS RIBAVIRIN | VIRUS-INFECTION | TELAPREVIR | BOCEPREVIR | INHIBITORS | Recombinant Proteins - therapeutic use | Uridine Monophosphate - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Male | Secondary Prevention | Polyethylene Glycols - therapeutic use | Young Adult | Time Factors | Ribavirin - administration & dosage | Adult | Female | Headache - chemically induced | Uridine Monophosphate - therapeutic use | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Adolescent | Liver Cirrhosis - pathology | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Protease inhibitors | Proteases | Gastrointestinal diseases | Clinical trials | Product development | Genetic aspects | Interferon | Hepatitis C | Health aspects | Liver cirrhosis | Viral antigens
Journal Article
Journal Article